CAR--话题@MedSci

#CAR-#

459篇内容 | 2272人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1781236, encodeId=492c1e812369c, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nature：这个意外突变，有望颠覆 CAR- T 治疗！, objectType=article, longId=139557, objectId=9ec413955e3c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ec413955e3c, replyNumber=0, likeNumber=54, createdTime=2019-03-14, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ec413955e3c, moduleTitle=Nature：这个意外突变，有望颠覆 CAR- T 治疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ec413955e3c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781214, encodeId=f0a31e81214d6, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=NEJM：振奋人心！迄今最长CAR-T治疗随访数据发布，MSKCC首次证实疾病负担低的患者获益很大，部分患者或被治愈, objectType=article, longId=128629, objectId=f01012862950, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f01012862950, replyNumber=0, likeNumber=47, createdTime=2018-09-24, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f01012862950, moduleTitle=NEJM：振奋人心！迄今最长CAR-T治疗随访数据发布，MSKCC首次证实疾病负担低的患者获益很大，部分患者或被治愈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f01012862950)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781226, encodeId=8e011e8122676, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Science：CAR-T细胞疗法新近进展, objectType=article, longId=134951, objectId=58c9134951a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58c9134951a2, replyNumber=0, likeNumber=68, createdTime=2018-09-17, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58c9134951a2, moduleTitle=Science：CAR-T细胞疗法新近进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58c9134951a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781258, encodeId=16171e81258d7, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=NICE拒绝将诺华的CAR-T疗法Kymriah（标价37万美元）用于治疗淋巴瘤, objectType=article, longId=149144, objectId=4fbb149144f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fbb149144f6, replyNumber=0, likeNumber=70, createdTime=2019-02-12, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fbb149144f6, moduleTitle=NICE拒绝将诺华的CAR-T疗法Kymriah（标价37万美元）用于治疗淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fbb149144f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781234, encodeId=cbcb1e8123448, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=陈文明教授：复发/难治多发性骨髓瘤的诊疗及CAR-T细胞疗法初探, objectType=article, longId=139390, objectId=63731393902c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63731393902c, replyNumber=0, likeNumber=55, createdTime=2018-07-29, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63731393902c, moduleTitle=陈文明教授：复发/难治多发性骨髓瘤的诊疗及CAR-T细胞疗法初探, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63731393902c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781237, encodeId=5a6a1e81237be, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=超级医保局挂牌，CAR-T治疗有望被颠覆…|BioWeek一周事, objectType=article, longId=139869, objectId=c53713986946, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c53713986946, replyNumber=0, likeNumber=74, createdTime=2018-11-09, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c53713986946, moduleTitle=超级医保局挂牌，CAR-T治疗有望被颠覆…|BioWeek一周事, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c53713986946)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781267, encodeId=69501e81267c6, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=迅速落地！医院开始接收患白血病儿童，英国医保正式覆盖CAR-T疗法, objectType=article, longId=154610, objectId=7d7415461004, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d7415461004, replyNumber=0, likeNumber=74, createdTime=2018-11-29, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d7415461004, moduleTitle=迅速落地！医院开始接收患白血病儿童，英国医保正式覆盖CAR-T疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d7415461004)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781230, encodeId=50651e81230bf, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=好疗效未必有好市场：全球**获批的CAR-T疗法销售数据尴尬了, objectType=article, longId=136644, objectId=05de13664424, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05de13664424, replyNumber=0, likeNumber=66, createdTime=2018-08-19, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05de13664424, moduleTitle=好疗效未必有好市场：全球**获批的CAR-T疗法销售数据尴尬了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05de13664424)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781263, encodeId=4ee31e81263f2, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=王建祥教授：中国CAR-T研究如日中天，在急性白血病领域不断深耕, objectType=article, longId=152262, objectId=3ecc15226290, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ecc15226290, replyNumber=0, likeNumber=52, createdTime=2019-03-27, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ecc15226290, moduleTitle=王建祥教授：中国CAR-T研究如日中天，在急性白血病领域不断深耕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ecc15226290)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781246, encodeId=cce21e8124631, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=定价47.5万美元的CAR-T疗法为进医保承诺无效退款？这事儿黄了！, objectType=article, longId=144205, objectId=6c9c1442059b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c9c1442059b, replyNumber=0, likeNumber=72, createdTime=2019-06-05, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c9c1442059b, moduleTitle=定价47.5万美元的CAR-T疗法为进医保承诺无效退款？这事儿黄了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c9c1442059b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781215, encodeId=e1361e8121515, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=NEJM：公布CAR-T癌症疗法历史性突破！癌症复发患者依然有效, objectType=article, longId=128693, objectId=2a5312869398, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a5312869398, replyNumber=0, likeNumber=57, createdTime=2018-07-31, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a5312869398, moduleTitle=NEJM：公布CAR-T癌症疗法历史性突破！癌症复发患者依然有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a5312869398)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781219, encodeId=4b521e81219fe, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=癌症终将被攻克多家公司改进CAR-T疗法, objectType=article, longId=131052, objectId=0c1f131052a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c1f131052a8, replyNumber=0, likeNumber=54, createdTime=2019-02-06, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c1f131052a8, moduleTitle=癌症终将被攻克多家公司改进CAR-T疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c1f131052a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781205, encodeId=397b1e81205c5, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=重复PLoS Pathog：CAR-T细胞治疗艾滋病！有效表达时间超2年！, objectType=article, longId=125422, objectId=a91112542290, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a91112542290, replyNumber=0, likeNumber=65, createdTime=2018-05-03, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a91112542290, moduleTitle=重复PLoS Pathog：CAR-T细胞治疗艾滋病！有效表达时间超2年！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a91112542290)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781266, encodeId=317e1e8126600, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Blood：抑制GM-CSF不仅可增强CAR-T细胞功能，还可减轻细胞因子释放综合征和神经炎症, objectType=article, longId=154294, objectId=773e15429406, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=773e15429406, replyNumber=0, likeNumber=72, createdTime=2018-11-25, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=773e15429406, moduleTitle=Blood：抑制GM-CSF不仅可增强CAR-T细胞功能，还可减轻细胞因子释放综合征和神经炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=773e15429406)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781250, encodeId=a6f11e81250a2, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=J Hematol Oncol:「CAR-T疗效不佳」，可能是肿瘤微环境引发的T细胞衰老, objectType=article, longId=145441, objectId=e0d214544180, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0d214544180, replyNumber=0, likeNumber=60, createdTime=2019-05-26, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0d214544180, moduleTitle=J Hematol Oncol:「CAR-T疗效不佳」，可能是肿瘤微环境引发的T细胞衰老, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0d214544180)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781235, encodeId=13b21e81235f9, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nat Med：同日两篇研究发现CAR-T毒性控制新理论，抑制IL-1可降低巨噬细胞产生CRS的风险, objectType=article, longId=139461, objectId=c25413946178, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c25413946178, replyNumber=0, likeNumber=69, createdTime=2018-08-18, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c25413946178, moduleTitle=Nat Med：同日两篇研究发现CAR-T毒性控制新理论，抑制IL-1可降低巨噬细胞产生CRS的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c25413946178)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781204, encodeId=a2d41e812043d, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=PLoS Pathog：CAR-T细胞疗法再现颠覆性进展，助力实现艾滋病功能性痊愈！, objectType=article, longId=125066, objectId=98f0125066ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98f0125066ce, replyNumber=0, likeNumber=67, createdTime=2018-05-29, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98f0125066ce, moduleTitle=PLoS Pathog：CAR-T细胞疗法再现颠覆性进展，助力实现艾滋病功能性痊愈！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98f0125066ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781227, encodeId=4f271e812279b, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T迎来利好中国药企或可与全球巨头同台竞技, objectType=article, longId=135275, objectId=554e1352e56b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=554e1352e56b, replyNumber=0, likeNumber=52, createdTime=2018-06-03, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=554e1352e56b, moduleTitle=CAR-T迎来利好中国药企或可与全球巨头同台竞技, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=554e1352e56b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781223, encodeId=f3581e812231a, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=美国将CAR-T疗法纳入医保, objectType=article, longId=134755, objectId=2542134e55d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2542134e55d0, replyNumber=0, likeNumber=74, createdTime=2018-10-23, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2542134e55d0, moduleTitle=美国将CAR-T疗法纳入医保, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2542134e55d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781249, encodeId=fab01e812496d, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Blood：接种疫苗可增强靶向胞内致癌WT1的CAR-T细胞的抗肿瘤效果！, objectType=article, longId=145271, objectId=0f981452e164, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f981452e164, replyNumber=0, likeNumber=61, createdTime=2019-06-11, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f981452e164, moduleTitle=Blood：接种疫苗可增强靶向胞内致癌WT1的CAR-T细胞的抗肿瘤效果！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f981452e164)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CAR-

2020-05-29

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Nature：这个意外突变，有望颠覆 CAR- T 治疗！

2019-03-14

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

NEJM：振奋人心！迄今最长CAR-T治疗随访数据发布，MSKCC首次证实疾病负担低的患者获益很大，部分患者或被治愈

2018-09-24

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Science：CAR-T细胞疗法新近进展

2018-09-17

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

NICE拒绝将诺华的CAR-T疗法Kymriah（标价37万美元）用于治疗淋巴瘤

2019-02-12

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

陈文明教授：复发/难治多发性骨髓瘤的诊疗及CAR-T细胞疗法初探

2018-07-29

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

超级医保局挂牌，CAR-T治疗有望被颠覆…|BioWeek一周事

2018-11-09

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

迅速落地！医院开始接收患白血病儿童，英国医保正式覆盖CAR-T疗法

2018-11-29

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

好疗效未必有好市场：全球**获批的CAR-T疗法销售数据尴尬了

2018-08-19

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

王建祥教授：中国CAR-T研究如日中天，在急性白血病领域不断深耕

2019-03-27

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

定价47.5万美元的CAR-T疗法为进医保承诺无效退款？这事儿黄了！

2019-06-05

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

NEJM：公布CAR-T癌症疗法历史性突破！癌症复发患者依然有效

2018-07-31

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

癌症终将被攻克多家公司改进CAR-T疗法

2019-02-06

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

重复PLoS Pathog：CAR-T细胞治疗艾滋病！有效表达时间超2年！

2018-05-03

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Blood：抑制GM-CSF不仅可增强CAR-T细胞功能，还可减轻细胞因子释放综合征和神经炎症

2018-11-25

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

J Hematol Oncol:「CAR-T疗效不佳」，可能是肿瘤微环境引发的T细胞衰老

2019-05-26

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Nat Med：同日两篇研究发现CAR-T毒性控制新理论，抑制IL-1可降低巨噬细胞产生CRS的风险

2018-08-18

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

PLoS Pathog：CAR-T细胞疗法再现颠覆性进展，助力实现艾滋病功能性痊愈！

2018-05-29

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T迎来利好中国药企或可与全球巨头同台竞技

2018-06-03

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

美国将CAR-T疗法纳入医保

2018-10-23

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Blood：接种疫苗可增强靶向胞内致癌WT1的CAR-T细胞的抗肿瘤效果！

2019-06-11

科室
- - 订阅+
  - 更多科室
工具
服务